Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Search Icon
Search Icon
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

mifepristone

mifepristone

23 results

Sort 23 results by:

Filter Applied. Clear All

Latest Posts

May 7, 2026 Charlotte Lozier Institute Launches Updated Unborn Baby Development Guide, New Pregnancy Calculator Charlotte Lozier Institute Launches Updated Unborn Baby Development Guide, New Pregnancy Calculator May 4, 2026 CLI OB-GYN Responds to Supreme Court’s Reinstatement of Mail-Order Abortions CLI OB-GYN Responds to Supreme Court’s Reinstatement of Mail-Order Abortions April 29, 2026 Public Comment: Lozier Institute on NIH’s Request for Information on Reducing Reliance on Human Embryonic Stem Cells in NIH-Supported Research Public Comment: Lozier Institute on NIH’s Request for Information on Reducing Reliance on Human Embryonic Stem Cells in NIH-Supported Research
Reset All Filters
mifepristone

Dangerous Deception: Not Telling Your Doctor About Abortion Pill Use Increases Health Risks

A new analysis of 423,000 confirmed abortions debunks the common abortion industry narrative that “there’s no medical reason to tell…

charlotte-lozier-institute Charlotte Lozier Institute
May 25, 2022
Please login to bookmark Close
mifepristone

Overlooked Dangers of Mifepristone, the FDA’s Reduced REMS, and Self-Managed Abortion Policies: Unwanted Abortions, Unnecessary Abortions, Unsafe Abortions

The failure of abortion providers to support and undertake prospective longitudinal studies of a nationally representative sample of women contributes…

mifepristone

Public Health Threat: Connecticut DPH Data Shows More Women Using Risky Abortion Method

Half of all Connecticut abortions are performed with potentially dangerous drugs which multiple peer-reviewed studies have linked to higher rates…

mifepristone

Public Health Threat: Chemical Abortion Leads to Significantly Higher Rate of ER Visits

As the Food and Drug Administration (FDA) works toward a December 16 decision on chemical abortion safeguards, a groundbreaking new…

CLI logo
mifepristone

FDA’s Race to Defend Women From Dangerous Drugs

Abortion advocates—seeking to exploit the COVID-19 crisis to advance unfettered access to abortion-inducing drugs—found a friend in federal court.  In…

CLI logo
mifepristone

Issues in Law and Medicine Spring 2017 Summaries

Issues in Law and Medicine is a peer-reviewed professional journal that has been published twice a year since 1985. It…

A preterm baby with medical tubes attached lies on an adult’s chest, while another adult gently holds the baby’s tiny hand, showing a caring, supportive moment in a hospital setting.
mifepristone

Abortion Increases Risk of Preterm Birth: More Evidence in New Publication

The recent systematic review published by Gabrielle Saccone and colleagues joins the long list of over 150 studies over the…

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image